Compared to Vδ2 T cells engineered with the isotype control (IgG) antibody, anti CTLA-4/anti PD-1 Vδ2 T cells showed a marked increase in melanoma spheroid infiltration and reduction of spheroid volume, indicating an improved killing efficacy of melanoma cells [201]. This evidence concerns the gene CTLA4 and melanoma.